Joshi Charuta N, Vossler David G, Spanaki Marianne, Draszowki Joseph F, Towne Alan R
1 Children's Hospital Colorado, University of Colorado, Anschutz Medical Campus, Denver, CO, USA.
2 UW Medicine | Valley Medical Center and University of Washington, Seattle, WA, USA.
Epilepsy Curr. 2019 Jul-Aug;19(4):221-226. doi: 10.1177/1535759719858647. Epub 2019 Jul 22.
This review compiles scientific data about the real dangers faced by people with epilepsy (PWE) who drive. Those include risks of motor vehicle accidents (MVA) in PWE as compared with controls (individuals without epilepsy) and as compared with persons with other medical conditions that impact fitness to drive. Data regarding Accident rates as related to seizure free intervals (SFI), single vs. multiple seizure events, and/or antiseizure drug (ASD) taper and reintroduction are discussed. Variation in state, national, and international laws and guidance for non-commercial and commercial drivers is highlighted, along with some related reasons for driving restrictions. The review concludes by emphasizing the importance of physicians educating patients about local driving laws and about risks of ASD non-adherence. The need for a broader, multi-stakeholder re-examination of driving regulations for PWE is noted.
本综述汇编了有关癫痫患者（PWE）驾车所面临的实际危险的科学数据。这些危险包括与对照组（无癫痫的个体）相比，以及与患有其他影响驾驶适宜性的医疗状况的人相比，癫痫患者发生机动车事故（MVA）的风险。讨论了与无癫痫发作间隔（SFI）、单次与多次癫痫发作事件和/或抗癫痫药物（ASD）减量及重新引入相关的事故率数据。强调了州、国家和国际层面针对非商业和商业驾驶员的法律及指南的差异，以及一些驾驶限制的相关原因。综述最后强调了医生告知患者当地驾驶法律以及不坚持服用抗癫痫药物的风险的重要性。指出需要对癫痫患者的驾驶法规进行更广泛的、多方利益相关者的重新审视。
Zotero 插件